Informed consent for neonatal trials: practical points to consider and a check list

Obtaining informed consent from parents of critically ill neonates can be challenging. The parental decision-making process is influenced by the severity of the child’s condition, the benefit–risk balance, their emotional state and the quality of the relationship with the clinical team. Independent...

Full description

Saved in:
Bibliographic Details
Main Authors: Donato Bonifazi, Evelyne Jacqz-Aigrain, Christine Kubiak, Mariette H E Driessens, Beate Aurich, Eric Vermeulen, Valéry Elie
Format: Article
Language:English
Published: BMJ Publishing Group 2020-02-01
Series:BMJ Paediatrics Open
Online Access:https://bmjpaedsopen.bmj.com/content/4/1/e000847.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846148419661332480
author Donato Bonifazi
Evelyne Jacqz-Aigrain
Christine Kubiak
Mariette H E Driessens
Beate Aurich
Eric Vermeulen
Valéry Elie
author_facet Donato Bonifazi
Evelyne Jacqz-Aigrain
Christine Kubiak
Mariette H E Driessens
Beate Aurich
Eric Vermeulen
Valéry Elie
author_sort Donato Bonifazi
collection DOAJ
description Obtaining informed consent from parents of critically ill neonates can be challenging. The parental decision-making process is influenced by the severity of the child’s condition, the benefit–risk balance, their emotional state and the quality of the relationship with the clinical team. Independent of local legislation, parents may prefer that consent is sought from both. Misconceptions about the absence of risks or unrealistic expectations about benefits should be openly addressed to avoid misunderstandings which may harm the relationship with the clinical team. Continuous consent can be sought where it is unclear whether the free choice of parental consent has been compromised. Obtaining informed consent is a dynamic process building on trusting relationships. It should include open and honest discussions about benefits and risks. Investigators may benefit from training in effective communication. Finally, involving parents in neonatal research including the development of the informed consent form and the process of obtaining consent should be considered standard practice.
format Article
id doaj-art-d02803dc163a480592694dd5c0a134fa
institution Kabale University
issn 2399-9772
language English
publishDate 2020-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Paediatrics Open
spelling doaj-art-d02803dc163a480592694dd5c0a134fa2024-12-01T06:10:09ZengBMJ Publishing GroupBMJ Paediatrics Open2399-97722020-02-014110.1136/bmjpo-2020-000847Informed consent for neonatal trials: practical points to consider and a check listDonato Bonifazi0Evelyne Jacqz-Aigrain1Christine Kubiak2Mariette H E Driessens3Beate Aurich4Eric Vermeulen5Valéry Elie6TEDDY European Network of Excellence for Paediatric Research, Via Luigi Porta 14, Pavia, ItalyParis University, Paris, FranceThe European Clinical Research Infrastructure Network (ECRIN), 5-7 Rue Watt, Paris, FranceDutch patient association for rare and genetic diseases (VSOP), Soest, The Netherlandsconsultant in drug safetyDutch patient association for rare and genetic diseases (VSOP), Soest, The NetherlandsDepartment of Paediatric Clinical Pharmacology and Pharmacogenetics, Robert Debré Hospital, 48 Boulevard Sérurier, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, FranceObtaining informed consent from parents of critically ill neonates can be challenging. The parental decision-making process is influenced by the severity of the child’s condition, the benefit–risk balance, their emotional state and the quality of the relationship with the clinical team. Independent of local legislation, parents may prefer that consent is sought from both. Misconceptions about the absence of risks or unrealistic expectations about benefits should be openly addressed to avoid misunderstandings which may harm the relationship with the clinical team. Continuous consent can be sought where it is unclear whether the free choice of parental consent has been compromised. Obtaining informed consent is a dynamic process building on trusting relationships. It should include open and honest discussions about benefits and risks. Investigators may benefit from training in effective communication. Finally, involving parents in neonatal research including the development of the informed consent form and the process of obtaining consent should be considered standard practice.https://bmjpaedsopen.bmj.com/content/4/1/e000847.full
spellingShingle Donato Bonifazi
Evelyne Jacqz-Aigrain
Christine Kubiak
Mariette H E Driessens
Beate Aurich
Eric Vermeulen
Valéry Elie
Informed consent for neonatal trials: practical points to consider and a check list
BMJ Paediatrics Open
title Informed consent for neonatal trials: practical points to consider and a check list
title_full Informed consent for neonatal trials: practical points to consider and a check list
title_fullStr Informed consent for neonatal trials: practical points to consider and a check list
title_full_unstemmed Informed consent for neonatal trials: practical points to consider and a check list
title_short Informed consent for neonatal trials: practical points to consider and a check list
title_sort informed consent for neonatal trials practical points to consider and a check list
url https://bmjpaedsopen.bmj.com/content/4/1/e000847.full
work_keys_str_mv AT donatobonifazi informedconsentforneonataltrialspracticalpointstoconsiderandachecklist
AT evelynejacqzaigrain informedconsentforneonataltrialspracticalpointstoconsiderandachecklist
AT christinekubiak informedconsentforneonataltrialspracticalpointstoconsiderandachecklist
AT mariettehedriessens informedconsentforneonataltrialspracticalpointstoconsiderandachecklist
AT beateaurich informedconsentforneonataltrialspracticalpointstoconsiderandachecklist
AT ericvermeulen informedconsentforneonataltrialspracticalpointstoconsiderandachecklist
AT valeryelie informedconsentforneonataltrialspracticalpointstoconsiderandachecklist